دورية أكاديمية

PRS54 - The Two-Year Therapy with Omalizumab in Children with Severe Persistent Uncontrolled Asthma: Dynamics of Quality of Life

التفاصيل البيبلوغرافية
العنوان: PRS54 - The Two-Year Therapy with Omalizumab in Children with Severe Persistent Uncontrolled Asthma: Dynamics of Quality of Life
المؤلفون: Namazova-Baranova, L, Vishneva, E, Dobrynina, E, Alekseeva, A, Levina, J, Efendieva, K, Antonova, E, Smirnov, V, Vinyarskaya, I, Selimzianova, L, Chemakina, D, Kalugina, V
المصدر: In Value in Health October-November 2017 20(9):A649-A649
قاعدة البيانات: ScienceDirect
الوصف
تدمد:10983015
DOI:10.1016/j.jval.2017.08.1510